• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病史和体格检查有助于确定肠易激综合征是否是导致该患者下消化道症状的原因吗?

Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?

作者信息

Ford Alexander C, Talley Nicholas J, Veldhuyzen van Zanten Sander J O, Vakil Nimish B, Simel David L, Moayyedi Paul

机构信息

Gastroenterology Division, McMaster University Medical Centre, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.

出版信息

JAMA. 2008 Oct 15;300(15):1793-805. doi: 10.1001/jama.300.15.1793.

DOI:10.1001/jama.300.15.1793
PMID:18854541
Abstract

CONTEXT

Many individuals experience lower gastrointestinal tract symptoms, most commonly attributable to functional conditions. These individuals are frequently diagnosed with irritable bowel syndrome (IBS) based on their symptoms; however, some may require additional testing or referral to specialists before this diagnosis is made.

OBJECTIVE

To systematically review the literature of the accuracy of individual symptoms and combinations of findings in diagnosing IBS.

DATA SOURCES

Search of MEDLINE and EMBASE (up to June 2008) for prospective studies reporting on unselected cohorts of adult patients with lower gastrointestinal tract symptoms recorded before investigation.

STUDY SELECTION

Studies prospectively evaluating accuracy of individual symptoms or combinations of findings compared with results from investigations of the lower gastrointestinal tract.

DATA EXTRACTION

Two authors independently assessed studies and extracted data to estimate likelihood ratios (LRs) of individual symptoms and combinations of findings in diagnosing IBS.

RESULTS

Ten studies evaluating 2355 patients were identified, with a summary prevalence of IBS following investigation of 57%. Individual symptom items yielded positive LRs from 1.2 (95% confidence interval [CI], 0.93-1.6) for passage of mucus per rectum to 2.1 (95% CI, 1.4-3.0) for looser stools at onset of abdominal pain and negative LRs from 0.29 (95% CI, 0.12-0.72) for no lower abdominal pain to 0.88 (95% CI, 0.72-1.1) for no passage of mucus per rectum in diagnosing IBS. The Manning criteria had a summary positive LR of 2.9 (95% CI, 1.3-6.4) and a summary negative LR of 0.29 (95% CI, 0.12-0.71). The Rome I criteria had a positive LR of 4.8 (95% CI, 3.6-6.5) and a negative LR of 0.34 (95% CI, 0.29-0.41). The Kruis scoring system provided a summary positive LR of 8.6 (95% CI, 2.9-26.0) and a summary negative LR of 0.26 (95% CI, 0.17-0.41). The Rome II and III criteria have not been studied.

CONCLUSIONS

Individual symptoms have limited accuracy for diagnosing IBS in patients referred with lower gastrointestinal tract symptoms. The accuracy of the Manning criteria and Kruis scoring system were only modest. Despite strong advocacy for use of the Rome criteria, only the Rome I classification has been validated. Future research should concentrate on validating existing diagnostic criteria or developing more accurate ways of predicting a diagnosis of IBS without the need for investigation of the lower gastrointestinal tract.

摘要

背景

许多人会出现下消化道症状,最常见的原因是功能性疾病。这些人常根据症状被诊断为肠易激综合征(IBS);然而,在做出该诊断之前,有些人可能需要进一步检查或转诊给专科医生。

目的

系统回顾关于个体症状及检查结果组合在诊断IBS时准确性的文献。

数据来源

检索MEDLINE和EMBASE(截至2008年6月),查找关于在调查前记录的未选择的成年下消化道症状患者队列的前瞻性研究。

研究选择

前瞻性评估个体症状或检查结果组合与下消化道检查结果相比准确性的研究。

数据提取

两位作者独立评估研究并提取数据,以估计个体症状及检查结果组合在诊断IBS时的似然比(LRs)。

结果

共确定了10项评估2355例患者的研究,调查后IBS的总体患病率为57%。个体症状项目的阳性似然比从直肠排出黏液的1.2(95%置信区间[CI],0.93 - 1.6)到腹痛发作时大便变稀的2.1(95% CI,1.4 - 3.0),阴性似然比从无下腹痛的0.29(95% CI,0.12 - 0.72)到直肠无黏液排出的0.88(95% CI,0.72 - 1.1),用于诊断IBS。曼宁标准的汇总阳性似然比为2.9(95% CI,1.3 - 6.4),汇总阴性似然比为0.29(95% CI,0.12 - 0.71)。罗马I标准的阳性似然比为4.8(95% CI,3.6 - 6.5),阴性似然比为0.34(95% CI,0.29 - 0.41)。克吕伊斯评分系统的汇总阳性似然比为8.6(95% CI,2.9 - 26.0),汇总阴性似然比为0.26(95% CI,0.17 - 0.41)。罗马II和III标准尚未进行研究。

结论

对于因下消化道症状转诊的患者,个体症状在诊断IBS时准确性有限。曼宁标准和克吕伊斯评分系统的准确性仅为中等。尽管大力提倡使用罗马标准,但只有罗马I分类得到了验证。未来的研究应集中于验证现有的诊断标准或开发更准确的方法来预测IBS诊断,而无需进行下消化道检查。

相似文献

1
Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?病史和体格检查有助于确定肠易激综合征是否是导致该患者下消化道症状的原因吗?
JAMA. 2008 Oct 15;300(15):1793-805. doi: 10.1001/jama.300.15.1793.
2
Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.验证罗马 III 标准在二级医疗机构中对肠易激综合征的诊断价值。
Gastroenterology. 2013 Dec;145(6):1262-70.e1. doi: 10.1053/j.gastro.2013.08.048. Epub 2013 Aug 28.
3
Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined?克鲁伊斯评分系统和曼宁标准在肠易激综合征诊断中的应用:联合使用是否更佳?
Acta Gastroenterol Belg. 1996 Oct-Dec;59(4):225-8.
4
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.肠易激综合征和功能性消化不良中报警特征的诊断率
Gut. 2004 May;53(5):666-72. doi: 10.1136/gut.2003.021857.
5
Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.通过补充病史和有限的诊断评估提高肠易激综合征症状性标准的诊断性能。
Am J Gastroenterol. 2016 Oct;111(10):1446-1454. doi: 10.1038/ajg.2016.308. Epub 2016 Aug 2.
6
Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.疑诊为肠易激综合征的患者——一项在初级保健中探索罗马 III 标准敏感性的横断面研究。
Am J Gastroenterol. 2013 Jun;108(6):972-80. doi: 10.1038/ajg.2013.15. Epub 2013 Feb 19.
7
Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.比较罗马 IV 标准与罗马 III 标准在二级医疗机构中对肠易激综合征的诊断。
Gut. 2021 Jun;70(6):1110-1116. doi: 10.1136/gutjnl-2020-322519. Epub 2020 Sep 24.
8
Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.结肠镜检查中患有与肠易激综合征相符症状的患者的器质性疾病患病率:横断面调查
Scand J Gastroenterol. 2015 Jul;50(7):816-23. doi: 10.3109/00365521.2015.1007079. Epub 2015 Jan 30.
9
[Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].[俄罗斯联邦的肠易激综合征:ROMERUS多中心观察性研究结果]
Ter Arkh. 2023 Feb 24;95(1):38-51. doi: 10.26442/00403660.2023.01.202043.
10
[A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].[罗马Ⅲ与罗马Ⅱ标准在肠易激综合征诊断中的比较]
Zhonghua Nei Ke Za Zhi. 2007 Aug;46(8):644-7.

引用本文的文献

1
Quality of life, functional impairment and healthcare experiences of patients with irritable bowel syndrome in Norway: an online survey.挪威肠易激综合征患者的生活质量、功能障碍及医疗保健体验:一项在线调查
BMC Gastroenterol. 2025 Mar 6;25(1):143. doi: 10.1186/s12876-025-03685-6.
2
Microbiome Shifts and Their Impact on Gut Physiology in Irritable Bowel Syndrome.肠道微生物组的改变及其对肠易激综合征肠道生理学的影响。
Int J Mol Sci. 2024 Nov 19;25(22):12395. doi: 10.3390/ijms252212395.
3
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.
验证对罗马IV标准的简单修改在二级医疗保健中用于肠易激综合征诊断的有效性。
Aliment Pharmacol Ther. 2025 Jan;61(2):354-362. doi: 10.1111/apt.18363. Epub 2024 Oct 28.
4
Concordance between Rome III and Rome IV criteria in irritable bowel syndrome.肠易激综合征中罗马III标准与罗马IV标准的一致性
Indian J Gastroenterol. 2024 Dec;43(6):1079-1081. doi: 10.1007/s12664-024-01624-z.
5
Raising the Bar in the Management of IBS-C.提高便秘型肠易激综合征的管理标准
Gastroenterol Hepatol (N Y). 2023 Oct;19(10):613-620.
6
Evaluation of the Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome in Conjunction With Clinical Examinations and Laboratory Investigations.结合临床检查和实验室检查对肠易激综合征基于症状的诊断标准进行评估。
Cureus. 2023 May 5;15(5):e38567. doi: 10.7759/cureus.38567. eCollection 2023 May.
7
Functional gastrointestinal disorders: History taking skills in practice.功能性胃肠病:实践中的问诊技巧。
Clin Med (Lond). 2021 Sep;21(5):e480-e486. doi: 10.7861/clinmed.2021-0189. Epub 2021 Aug 11.
8
Irritable Bowel Syndrome in a Population of a Developing Country: Prevalence and Association.一个发展中国家人群中的肠易激综合征:患病率及相关性
Cureus. 2020 May 14;12(5):e8112. doi: 10.7759/cureus.8112.
9
Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.肠易激综合征与糜烂性食管炎重叠及罗马标准在临床环境中诊断肠易激综合征的表现。
Mol Med Rep. 2019 Jul;20(1):787-794. doi: 10.3892/mmr.2019.10284. Epub 2019 May 23.
10
Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.使用血浆抗 CDTB 和抗微管蛋白水平进行肠易激综合征的第二代生物标志物检测。
Dig Dis Sci. 2019 Nov;64(11):3115-3121. doi: 10.1007/s10620-019-05684-6. Epub 2019 May 31.